August 23, 2006
Pharmacosmos participates in the CPhI 2006 Worldwide
(International Convention on Pharmaceutical Ingredients and
Intermediates). The CPhI 2006 is held in Paris-Nord Villepente,
France during the period October 3 - 5, 2006.
For additional information about the CPhI 2006, please visit the
CPhI
Website.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
Danish company and operates in more than 50 countries across
Europe, the Americas and Asia. Its facilities are approved by the
Danish Medicines Agency and the US Food & Drug
Administration.